Jardiance is a once-daily oral medication used to control blood sugar levels in patients with type 2 diabetes.
This is achieved by helping the kidneys remove glucose from the blood through urine.
Jardiance is not used to lose weight or control blood pressure, but it can help you at the same time. pharma consulting companies. It is used as part of a treatment plan, which may include exercise, diet and special medical care.
The drug was approved by the European Commission in May 2014. As a relatively new drug, its long-term effects within a few years are unclear.
This is achieved by helping the kidneys remove glucose from the blood through urine.
Jardiance is not used to lose weight or control blood pressure, but it can help you at the same time. pharma consulting companies. It is used as part of a treatment plan, which may include exercise, diet and special medical care.
The drug was approved by the European Commission in May 2014. As a relatively new drug, its long-term effects within a few years are unclear.
About Jardiance
Product Name: JardianceCommon name: Empagliflozin
Drug category: SGLT2 inhibitor
Manufacturers: Boehringer Ingelheim and Eli Lilly and Diabetes
How Jardiance helps type 2 diabetes
By expelling excess glucose from the urine, Jardinance helps improve blood sugar control in patients with type 2 diabetes. named Patient supply This can lead to improved HbA1c levels, thereby reducing the risk of diabetes-related complications.Since calories in glucose are also excreted from the body, the use of Jardiance may cause weight loss. Since type 2 diabetes is closely related to body weight-about 90% of newly diagnosed type 2 diabetes exceeds its ideal body weight-this helps maintain healthy body weight.
Jardiance is used as part of the treatment plan, in addition to Jardiance treatment, it is also important to maintain other aspects (such as physical exercise).
Mechanism of action
Empagliflozin is an SGLT2 inhibitor, a drug class that helps prevent sodium and glucose transporters that are filtered from the blood as the kidney is reabsorbed back into the blood.Empagliflozin allows large amounts of sugar to be removed by urination. SGLT2 protein accounts for 90% of glucose reabsorbed into the blood.
No comments:
Post a Comment